Sagar Lonial, MD, FACP; Winship Cancer Institute of Emory University; 5Live #ASH21

Multiple Myeloma /

Multiple Myeloma 139 videos

of 13

139 videos

Multiple Myeloma

Sagar Lonial, MD, FACP; Winship Cancer Institute of Emory University; 5Live #ASH21

4:52

Key insights from the 2021 Annual Hematology meeting in Atlanta
Nina Shah, MD; University of California San Francisco; 5Live #ASH21

7:06

Key insights from the 2021 Annual Hematology meeting in Atlanta
Aligning Induction Therapy for Each Patient_Saad Usmani, MD, MBA, FACP

44:37
Virtual Challenging Case Clinic: Multiple Myeloma_Agents Targeting BCMA_Noopur Raje, MD

50:24
Expert Insights: Regimen Choice and Newly Approved Agents in Relapsed/Refractory Multiple Myeloma_Sagar Lonial, MD, FACP_Thomas Martin, MD

18:41
Regimen Choice: Doublet vs Triplet_Sagar Lonial, MD, FACP; #soho2021

15:41
Updates on CAR T Therapy for Multiple Myeloma_Nina Shah, MD; #HemeWorkshop2021

9:21
Integrated Genomic and Epigenomic Analysis of Multiple Myeloma_Ben Barwick, PhD; #HemeWorkshop2021

15:27
Off the Shelf Cellular Therapy in Multiple Myeloma_Sham Mailankody, MBBS; #HemeWorkshop2021

9:26
Treating smoldering MM_Nisha Joseph, MD; #DDHO2021

3:11
How to treat newly diagnosed myeloma and New Targets and agents in MM_Sagar Lonial, MD, FACP and Kenneth Anderson, MD; #DDHO2021

4:00
Next Page

of 13

ABOUT

Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.

The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.

CONNECT

support@bioascend.com

(888) 476-9129

980 North Michigan Avenue, Suite 1400, Chicago, IL 60611

Terms and Conditions | Privacy Policy

Sagar Lonial, MD, FACP; Winship Cancer Institute of Emory University; 5Live #ASH21

Nina Shah, MD; University of California San Francisco; 5Live #ASH21

Aligning Induction Therapy for Each Patient_Saad Usmani, MD, MBA, FACP

Virtual Challenging Case Clinic: Multiple Myeloma_Agents Targeting BCMA_Noopur Raje, MD

Expert Insights: Regimen Choice and Newly Approved Agents in Relapsed/Refractory Multiple Myeloma_Sagar Lonial, MD, FACP_Thomas Martin, MD

Regimen Choice: Doublet vs Triplet_Sagar Lonial, MD, FACP; #soho2021

Updates on CAR T Therapy for Multiple Myeloma_Nina Shah, MD; #HemeWorkshop2021

Integrated Genomic and Epigenomic Analysis of Multiple Myeloma_Ben Barwick, PhD; #HemeWorkshop2021

Off the Shelf Cellular Therapy in Multiple Myeloma_Sham Mailankody, MBBS; #HemeWorkshop2021

Treating smoldering MM_Nisha Joseph, MD; #DDHO2021

How to treat newly diagnosed myeloma and New Targets and agents in MM_Sagar Lonial, MD, FACP and Kenneth Anderson, MD; #DDHO2021

Share this video

Embed